The document discusses the potential necessity and harm of using antipsychotic medications, particularly haloperidol and quetiapine, in treating delirium in elderly patients, highlighting that there is no solid evidence supporting their effectiveness. It emphasizes focusing on non-pharmacological interventions and addressing underlying causes of delirium rather than prescribing antipsychotics, which may increase risks such as mortality and delirium severity. Recommendations include behavioral interventions and reserving antipsychotics for severe cases of self-harm danger, treating for the shortest duration with minimal dosage.